Ah, much better! I guess I can ignore the cyclondex files and grab a plain old zip?
-----Original Message----- From: Tamás Cservenák <ta...@cservenak.net> Sent: Monday, December 18, 2023 3:49 PM To: Maven Users List <users@maven.apache.org> Cc: subharaj.ma...@gmail.com Subject: Re: Maven 4.0 release timeline CAUTION: This email originated from outside our organisation - ta...@cservenak.net Do not click on links, open attachments, or respond unless you recognize the sender and can validate the content is safe. I really recommend alpha10, distros are here https://clicktime.symantec.com/15t6V3WB3Q9UkWhf5JPD6?h=DNfkwbsM2Nbwr9Re8FSzo--npL69CABPYMYoaHsSC-A=&u=https://repository.apache.org/content/repositories/maven-2050/org/apache/maven/apache-maven/4.0.0-alpha-10/ Thanks T On Mon, Dec 18, 2023, 21:48 <mark.yagnatin...@barclays.com.invalid> wrote: > Navigating that directory tree seems a bit intimidating... can I try > alpha-8 or better wait for alpha-10 to officially come out? > > -----Original Message----- > From: Tamás Cservenák <ta...@cservenak.net> > Sent: Monday, December 18, 2023 3:43 PM > To: Maven Users List <users@maven.apache.org> > Cc: subharaj.ma...@gmail.com > Subject: Re: Maven 4.0 release timeline > > > CAUTION: This email originated from outside our organisation - > ta...@cservenak.net Do not click on links, open attachments, or > respond unless you recognize the sender and can validate the content is safe. > ...or,.just go to staging repo > > https://clicktime.symantec.com/15siaWLYGbnA1MrGqWQwt?h=qkVv-eG-rGmVca6 > UeWqg9iHAifq1sVHsvsDmSfLKZ2o=&u=https://clicktime.symantec.com/15t6QDJ > tanTtLZsjXjz4U?h=4Jzcps2egc7Hk1dplHDiulcv9nRA0wSTiAQlv1W8Bro=&u=https: > //repository.apache.org/content/repositories/maven-2050 > download the distro and try on some of your projects? > > In case of problems be so kind to report the issues so we can iron > them out. > > Imho, alpha 10 is in very good shape. Alpha-9 had a nasty bug and > could remain running the process. Do not use it. > > Thanks > T > > On Mon, Dec 18, 2023, 21:39 <mark.yagnatin...@barclays.com.invalid> wrote: > > > I'm not the original asker but this kind of answer tends to annoy me. > > Yes, there is no "official" release timeline, you're obviously not > > going to promise anything, all this is (hopefully?) clear, BUT! > > You no doubt have GUESSES. And your guesses are no doubt better > > than that of most uninformed outsiders. > > As an outsider, I have no idea what the "status" of maven 4 is, and > > I can't even begin to guess how I would find out. > > Should I try to catch up on the last few years of traffic on the > > developer email lists? > > Or perhaps the answer can be divined from the issue tracker? If so, how? > > Is it expected that alpha-10 will be the last alpha, and the next > > build will be a beta? > > If that is NOT what you expect, then what's the primary hold up? > > Are there major features that have yet to be implemented? > > Or perhaps the features are mostly done but they're still a bit buggy? > > Or perhaps the code quality is pretty solid and you just want to > > reserve the right to make backwards incompatible changes, and > > there's a policy to not do that after hitting beta? > > > > You get the idea. As an insider, you probably think to yourself > > "there's no telling when we'll be done; it depends on a zillion > > unpredictable things". > > But as outsiders, we don't even know whether the ETA is a few months > > or a few years or a few decades or perhaps just a few weeks. > > > > Sorry if that came off as a bit of a rant :) > > > > > > -----Original Message----- > > From: Karl Heinz Marbaise <khmarba...@gmx.de.INVALID> > > Sent: Monday, December 18, 2023 3:18 PM > > To: Maven Users List <users@maven.apache.org>; Debraj Manna < > > subharaj.ma...@gmail.com> > > Subject: Re: Maven 4.0 release timeline > > > > > > CAUTION: This email originated from outside our organisation - > > khmarba...@gmx.de.INVALID Do not click on links, open attachments, > > or respond unless you recognize the sender and can validate the > > content is safe. > > On 18.12.23 06:27, Debraj Manna wrote: > > > Can someone let me know when Maven 4 is expected to be released? > > > Where can I view its release timelines? > > > > > > > We are an open source project. We don't have a release timeline. > > > > Maven 4.0.0 will be there when it's there. > > > > > > If you want to help testing, there is 4.0.0-alpha-9 version > > available (at the moment the VOTE for 4.0.0-alpha-10 is running developers > > list).. > > > > > > > > https://clicktime.symantec.com/15t6EYvKfZ6hWgDtSdBmE?h=enuexfuM5c9xR > > Z5X0oZzhj669n395kTA5hIdhUOxXyY=&u=https://clicktime.symantec.com/15t > > 5ejZL3AGSyEFA9Aedx?h%3DABJzOQGm-e1Zxyu > > IqUZPLWnHHC2LmzcP6V9UINAuTSc=&u=https://clicktime.symantec.com/15t5j > > Zkcus1931GMBGnsW?h=aAZLedKsowXWW-3Z-WnWmkI4H71A9BrQiqYTxH6hqWk=&u=ht > > tps://clicktime.symantec.com/15siQqw > > yMNQyBUCRkPcee?h=-wnFgkT4h16bjz0t2Vuc_NutxQbPp0L_p6KY3P3WB2E=&u=https: > > //maven.apache.org/download.cgi > > > > https://clicktime.symantec.com/15t69ij3CwR76jPxu4ncc?h=GfK7jRGQ-5KWG > > I6Z9jbAEouZQPMl7EIW6YcQIomuX0o=&u=https://clicktime.symantec.com/15t > > 5ZuN3aYarZHREbcFVL?h%3Df4YJm-aS7T_bpjO > > AtqB_jneksRphxbi0aG911AdXT1E=&u=https://clicktime.symantec.com/15t5e > > jZLTFKYd4SRdiPit?h=LX1jJOzqd3bLwq21pgLA2NMdovCdqX9n1GXAPx3KO70=&u=ht > > tps://clicktime.symantec.com/15siL1k > > gtkjNmXNWCqDW2?h=BX1saw3vPZ85tRY4Qc9ZmbpOGkojF6vC2umq1TvP1eM=&u=https: > > //maven.apache.org/docs/history.html > > > > https://clicktime.symantec.com/15t6KP7c8AnHvd3ozBaur?h=-70HebZ3AGRsC > > g_xOyWXFdOomJjDXv_uRyYtHU93KN4=&u=https://clicktime.symantec.com/15t > > 5jZkcVmx3PB55gj3na?h%3DL9e7tA5cT0v2zyk > > QUoinwwWFS6c1VuE5zuM7Lmb8XwE=&u=https://clicktime.symantec.com/15t5p > > PwuNUgjSx6GiqC28?h=WWvg4OngLTq1LcWEVErBEolB35AOOYBjFU0blXj6fFw=&u=ht > > tps://clicktime.symantec.com/15siVg9 > > Foz6ZbR2MHx1oG?h=C_JJFO_gli3dfK9BJoJ1t22_wu2YHA7V4ywpVxFiPlA=&u=https: > > //maven.apache.org/mailing-lists.html > > > > Kind regards > > Karl Heinz Marbaise > > Apache Maven PMC Chairman > > > > > > -------------------------------------------------------------------- > > - To unsubscribe, e-mail: users-unsubscr...@maven.apache.org > > For additional commands, e-mail: users-h...@maven.apache.org > > > > This message is for information purposes only. It is not a > > recommendation, advice, offer or solicitation to buy or sell a > > product or service, nor an official confirmation of any transaction. > > It is directed at persons who are professionals and is intended for > > the > > recipient(s) only. It is not directed at retail customers. This > > message > is subject to the terms at: > > > https://clicktime.symantec.com/15sizfJxZgC855ytZJQgz?h=3voR8g2XaCqfAjj > ZLcBvchvlPd7niApVYl9kKJuW4X0=&u=https://clicktime.symantec.com/15t79h4 > SiKcE45K3RmaQ4?h=386zNjhGjtFZKMcyKar2TV3Jafl02hA62LukYLYLoOw=&u=https: > //www.cib.barclays/disclosures/web-and-email-disclaimer.html > . > > > > For important disclosures, please see: > > https://clicktime.symantec.com/15t64tXkkKjWgna3MWPTz?h=h0k-k9gHX0Jyo > > DG3-dmiqOdkwCPKPoLqP_QnwQr4QZQ=&u=https://clicktime.symantec.com/15s > > iuq7g74WXf99y1k1YN?h%3DIswND1SsUj6jPBn > > AQ25pI03Yrip4Fb40LbWhFeGfT3A=&u=https://clicktime.symantec.com/15t6z > > 2fso6F3EBfCLen6p?h=oGETYLl2q3nwGdR6oFnB55WYr5GiCe8J19ndBR4sQc4=&u=ht > > tps://www.cib.barclays/disclosures/s > > ales-and-trading-disclaimer.html regarding marketing commentary from > > Barclays Sales and/or Trading desks, who are active market > > participants; > > https://clicktime.symantec.com/15t5uE9Bq6NKrtvCGPbAk?h=WGT2rvU9dccDE > > BzxBdoj1uiE_iBgRhroqOA77z94TS8=&u=https://clicktime.symantec.com/15s > > ifLXpjDTkRJgCP4p6W?h%3DvgA6hjZek3ZVk_x > > Kn8kqhC6hIQRHHWp-8qQNmirXDGY=&u=https://clicktime.symantec.com/15t6Z > > shTW1q5ATXacrnMi?h=spOS7WUPKlYI9BbNCie3WBvSe0GcdKyXzRR5qsqneVM=&u=ht > > tps://www.cib.barclays/disclosures/b > > arclays-global-markets-disclosures.html > > regarding our standard terms for Barclays Corporate and Investment > > Bank where we trade with you in principal-to-principal wholesale > > markets transactions; and in respect to Barclays Research, including > > disclosures relating to specific issuers, see: > https://clicktime.symantec.com/15siFBZQS93nMaYafGpMQ?h=7SEAYHsYc8GqllC > A9QU7CPBG1yVxx6q0UKBl4DhkexA=&u=https://clicktime.symantec.com/15t5ZuN > 3zddxD7cW69zaG?h=Gl-gefN79RuR94I07-xb-Tk-CNam0oH1c_-Kw0CHjME=&u=http:/ > /publicresearch.barclays.com > . > > ____________________________________________________________________ > > __ > > ____________ > > > > If you are incorporated or operating in Australia, read these > > important > > disclosures: > > https://clicktime.symantec.com/15t5z4LUHi3vGqk7owzKN?h=bwfDHtKrv5i1Z > > gB7KkBCNcXgzRVO57du15ATmihmdOY=&u=https://clicktime.symantec.com/15s > > ikAj7Bq9LqFW7vdDF8?h%3DF4wY-fRb3iEFXGV > > Uf81j9jMY86UU5tAvr_lkw6Z9n6c=&u=https://clicktime.symantec.com/15t6j > > Y62RFCFzMBRhyaex?h=8H2v29dFh8_nyx8ylhln9299w5TnsB-S1cra0oWHuqk=&u=ht > > tps://www.cib.barclays/disclosures/i > > mportant-disclosures-asia-pacific.html > > . > > > > ____________________________________________________________________ > > __ ____________ For more details about how we use personal > > information, see our privacy > > notice: > https://clicktime.symantec.com/15sipzvPeSpwFCL3UBcPk?h=Rip9XxtA8tlObzI > skgzvnMyDxXh7aMSApsjmEUDZC6E=&u=https://clicktime.symantec.com/15t6uCU > bLUZSpEqGo6NxC?h=mLknyfmRXQOw-fmrFE4MBWUqoH4MUrsr9JBCKcjXSFw=&u=https: > //www.cib.barclays/disclosures/personal-information-use.html > . > > > > > > ____________________________________________________________________ > > __ > > ____________ > > > > This message is for information purposes only. It is not a > recommendation, advice, offer or solicitation to buy or sell a product > or service, nor an official confirmation of any transaction. It is > directed at persons who are professionals and is intended for the > recipient(s) only. It is not directed at retail customers. This message is > subject to the terms at: > https://clicktime.symantec.com/15t79h4SiKcE45K3RmaQ4?h=386zNjhGjtFZKMcyKar2TV3Jafl02hA62LukYLYLoOw=&u=https://www.cib.barclays/disclosures/web-and-email-disclaimer.html. > > For important disclosures, please see: > https://clicktime.symantec.com/15t74rsAFhvde8V7tDBFS?h=QjPu8g1jFYzvYdV > J2BDV142aPSXozhBk9q-B7uRMp8g=&u=https://www.cib.barclays/disclosures/s > ales-and-trading-disclaimer.html regarding marketing commentary from > Barclays Sales and/or Trading desks, who are active market > participants; > https://clicktime.symantec.com/15t6ehtjxdWfaQMWARBWL?h=rSTsOsqRWtP81fx > lenIXFl2JNFS0vFu3YcaVOp4RJJI=&u=https://www.cib.barclays/disclosures/b > arclays-global-markets-disclosures.html > regarding our standard terms for Barclays Corporate and Investment > Bank where we trade with you in principal-to-principal wholesale > markets transactions; and in respect to Barclays Research, including > disclosures relating to specific issuers, see: > https://clicktime.symantec.com/15t5ZuN3zddxD7cW69zaG?h=Gl-gefN79RuR94I07-xb-Tk-CNam0oH1c_-Kw0CHjME=&u=http://publicresearch.barclays.com. > ______________________________________________________________________ > ____________ > > If you are incorporated or operating in Australia, read these > important > disclosures: > https://clicktime.symantec.com/15t6pNHJsrsrQJ1MFXyoa?h=Q2M2Ym9iHv7RNTK > YvwJ0mMzeplKI2KAcu1W5GwEphIw=&u=https://www.cib.barclays/disclosures/i > mportant-disclosures-asia-pacific.html > . > > ______________________________________________________________________ > ____________ For more details about how we use personal information, > see our privacy > notice: > https://clicktime.symantec.com/15t6uCUbLUZSpEqGo6NxC?h=mLknyfmRXQOw-fmrFE4MBWUqoH4MUrsr9JBCKcjXSFw=&u=https://www.cib.barclays/disclosures/personal-information-use.html. > > > ______________________________________________________________________ > ____________ > > --------------------------------------------------------------------- > To unsubscribe, e-mail: users-unsubscr...@maven.apache.org > For additional commands, e-mail: users-h...@maven.apache.org This message is for information purposes only. It is not a recommendation, advice, offer or solicitation to buy or sell a product or service, nor an official confirmation of any transaction. It is directed at persons who are professionals and is intended for the recipient(s) only. It is not directed at retail customers. This message is subject to the terms at: https://www.cib.barclays/disclosures/web-and-email-disclaimer.html. For important disclosures, please see: https://www.cib.barclays/disclosures/sales-and-trading-disclaimer.html regarding marketing commentary from Barclays Sales and/or Trading desks, who are active market participants; https://www.cib.barclays/disclosures/barclays-global-markets-disclosures.html regarding our standard terms for Barclays Corporate and Investment Bank where we trade with you in principal-to-principal wholesale markets transactions; and in respect to Barclays Research, including disclosures relating to specific issuers, see: http://publicresearch.barclays.com. __________________________________________________________________________________ If you are incorporated or operating in Australia, read these important disclosures: https://www.cib.barclays/disclosures/important-disclosures-asia-pacific.html. __________________________________________________________________________________ For more details about how we use personal information, see our privacy notice: https://www.cib.barclays/disclosures/personal-information-use.html. __________________________________________________________________________________
